Influence of thyrotrophin-releasing hormone on thermoregulation in newborn lambs.
This study examined the effect of thyrotrophin-releasing hormone (TRH) administration on thermoregulation in the newborn. Twin lambs were either delivered near-term by caesarean section or born vaginally at term. Colonic temperature, O2 consumption, CO2 production, breathing and heart rates, plus plasma thyroid hormone and nonesterified fatty acid (NEFA) concentrations and thermogenic activity (i.e. GDP binding) of brown adipose tissue (BAT) were measured. In caesarean section delivered lambs colonic temperature decreased rapidly after birth, a response that was greater in the group designated for TRH treatment, in which colonic temperature fell to below 36.0 degrees C at 80 min of life, prior to TRH administration. At this age colonic temperature had been restored to a mean of 38.70 degrees C in controls. TRH had no influence on the composition or thermogenic activity of BAT. The incidence of shivering was not influenced by TRH, but treated lambs maintained a higher rate of O2 consumption and ventilation compared with controls after colonic temperature had been restored to 38.56 degrees C. TRH appeared to promote fat oxidation as O2 consumption remained unchanged and CO2 production declined by a greater rate in treated lambs, resulting in a lower respiratory quotient compared to controls. Heart rate and plasma concentrations of NEFA increased following TRH administration although this did not result in values greater than controls. Normothermic lambs born vaginally had BAT with a greater thermogenic activity, higher plasma thyroid hormone and NEFA concentrations compared with caesarean section delivered lambs, but a thermogenic response was not observed to TRH despite a rise in thyroid hormone concentrations. In conclusion, TRH can improve thermoregulation, an effect that could be linked to an increase in fat oxidation.
Bird
J A
JA
School of Animal and Microbial Sciences, University of Reading, Whiteknights, Reading, Berks., UK.
Clarke
L
L
Symonds
M E
ME
D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001831:Body Temperature / Q000187:drug effects / Q000502:physiology; D001833:Body Temperature Regulation / Q000187:drug effects* / Q000502:physiology; D015331:Cohort Studies; D036861:Delivery, Obstetric / Q000379:methods / Q000662:veterinary; D005230:Fatty Acids, Nonesterified / Q000097:blood / Q000378:metabolism; D005260:Female; D006854:Hydrocortisone / Q000097:blood / Q000378:metabolism; D007275:Injections, Intravenous / Q000662:veterinary; D010101:Oxygen Consumption / Q000187:drug effects / Q000502:physiology; D011247:Pregnancy; D012756:Sheep / Q000502:physiology*; D013963:Thyroid Hormones / Q000097:blood / Q000145:classification / Q000378:metabolism; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*
D005230:Fatty Acids, Nonesterified; D013963:Thyroid Hormones; D013973:Thyrotropin-Releasing Hormone; D006854:Hydrocortisone